Company News for Jan 12, 2021

Zacks Equity Research Published on January 12, 2021

Shares of Mesoblast Limited (MESO - Free Report) jumped 31.6% after the company announced that its rexlemestrocel-L reduced heart attacks, strokes and cardiac deaths.
The ODP Corporation’s (ODP - Free Report) shares rose 19.4% after USR Parent, Inc. proposed to acquire the company for $40 per share in cash.
Shares of Eli Lilly and Company (LLY - Free Report) surged 11.7% after the company announced that its Alzheimer's treatment slowed the decline of patients' ability to think by 32% in a phase 2 trial.
AZZ Inc.’s (AZZ - Free Report) shares rose 0.6% after the company reported third quarter of fiscal 2021 earnings of $0.80 per share, beating the Zacks Consensus Estimate of $0.58.

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.